Novartis AG, et al. v. Novadoz Pharmaceuticals LLC, et al.

District Court, D. New Jersey·Decided August 4, 2026·No. 2:25-cv-00849·Unknown

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

NOVARTIS AG, et al., Civil Action No.

Plaintiffs, 25-cv-00849 (EP) (JRA)

v. OPINION AND ORDER NOVADOZ PHARMACEUTICALS LLC, et al.,

Defendants.

José R. Almonte, U.S.M.J. Defendants MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, and Novadoz Pharmaceuticals LLC (collectively “Defendants”) move to compel Plaintiffs Novartis AG and Novartis Pharmaceuticals Corporation (collectively “Plaintiffs”) “to produce non-privileged documents responsive to [Defendants’] Request for Production . . . No. 34—‘[a]ll Documents referring or relating to [Plaintiffs’] decision to file this Action against [Defendants].’”1 Dkt. No. 89 at 1 (“the Motion”). Plaintiffs oppose the Motion. Dkt. No. 90. The Court has considered the Motion on the papers and decides it without oral argument. See Fed. R. Civ. P. 78(b); L.Civ.R. 78.1(b). For reasons explained below, the Motion is DENIED WITHOUT PREJUDICE.

1 The Court assumes the parties’ familiarity with the facts of this case; therefore, the Court will not provide a detailed background and procedural history of this matter. Although technically not filed as a motion, the parties’ submissions are sufficient for the Court to construe it as one. I. FACTUAL BACKGROUND AND PROCEDURAL HISTORY For brief background, Plaintiffs filed this action based on Defendants’ anticipated launch of a generic version of Plaintiffs’ ENTRESTO® heart failure

medication that Plaintiffs allege is nearly identical in appearance to ENTRESTO® and will be sold under Defendant Novadoz Pharmaceuticals’ trademark. Compl. ¶¶ 1–10, Dkt. No. 1. Plaintiffs brought claims against Defendants for trademark infringement, trade dress infringement, and unfair competition. Id. Plaintiffs’ lawsuit is aimed at preventing “consumer and reputational harm” and preventing Defendants from “creating consumer confusion and harming the goodwill of the NOVARTIS trademark

and the trade dresses of the ENTRESTO® tablets.” Id. ¶ 10. The instant Motion centers around Defendants’ request for Plaintiffs to produce non-privileged discovery related to Plaintiffs’ subjective motivations for filing this action. Dkt. No. 89 at 1. Defendants claim that this information is relevant, but Plaintiffs vehemently disagree. II. LEGAL STANDARD Courts evaluate discovery disputes under the purview of Rule 26 of the Federal

Rules of Civil Procedure. Rule 26(b)(1) permits parties to seek discovery concerning “any nonprivileged matter that is relevant to any party’s claim or defense” and that is “proportional to the needs of the case, considering . . . the importance of the discovery in resolving the issues, and whether the burden or expense of the proposed discovery outweighs its likely benefit.” Fed. R. Civ. P. 26(b)(1). The movant—here, Defendants—bears the burden of demonstrating that the information sought is relevant. Columbus Life Ins. Co. v. Wilmington Tr., N.A., 344 F.R.D. 207, 215 (D.N.J. 2023) (citation omitted). Further, “[a]lthough the scope of discovery under the Federal Rules is unquestionably broad, this right is not unlimited and may be circumscribed.”

Bayer AG v. Betachem, Inc., 173 F.3d 188, 191 (3d Cir. 1999) (citation omitted). Once the party seeking discovery demonstrates the relevance of the requested information, the opposing party must “show why discovery should not be permitted.” Cordero v. Warren, No. 12-cv-2136, 2016 WL 8199305, at *2 (D.N.J. Oct. 4, 2016) (citation modified), aff’d, 2017 WL 2367049 (D.N.J. May 31, 2017). This Court maintains broad discretion to resolve discovery issues. See

Wisniewski v. Johns-Manville Corp., 812 F.2d 81, 90 (3d Cir. 1987). On motion or on its own, the Court must limit the frequency or extent of discovery otherwise allowed if it determines that: “(i) the discovery sought is unreasonably cumulative or duplicative, or can be obtained from some other source that is more convenient, less burdensome, or less expensive; (ii) the party seeking discovery has had ample opportunity to obtain the information by discovery in the action; or (iii) the proposed discovery is outside the [general] scope permitted by Rule 26(b)(1).” Fed. R. Civ. P.

26(b)(2)(C); see also Goodman v. Burlington Coat Factory Warehouse Corp., 292 F.R.D. 230, 232 (D.N.J. 2013) (citations omitted) (observing that Rule 26’s proportionality standard permits the Court to guard against discovery into otherwise proper subjects of inquiry). III. DISCUSSION Defendants served on Plaintiffs Request for Production No. 34, asking Plaintiffs to produce “[a]ll Documents referring or relating to [Plaintiffs’] decision to file this

Action against [Defendants].” Dkt. No. 89 at 1. Defendants advance two relevance arguments to support their request: (1) that it is relevant to their laches defense; and (2) that it is relevant to their “potential” claim for attorneys’ fees under the Lanham Act. Id. at 2–3. The Court will address each argument in turn. A. Laches Defense Defendants argue first that Plaintiffs’ “decision to file suit is relevant to

[Defendants’] laches defense.” Id. at 2. The Court disagrees. Laches is an equitable principle. When a claim lacks a specific statute of limitations, such as claims arising under the Lanham Act, courts look to the laches defense to determine whether the claim should be time-barred. See Kars 4 Kids Inc. v. Am. Can!, 98 F.4th 436, 443–44 (3d Cir. 2024) [hereinafter “Kars 4 Kids II”]. To determine whether laches bars a Lanham Act claim, courts consider two elements: “(1) whether the plaintiff inexcusably delayed in bringing suit, and (2) whether the defendant was prejudiced

as a result of the delay.” Id. (citing Santana Prods., Inc. v. Bobrick Washroom Equip., Inc., 401 F.3d 123, 138 (3d Cir. 2005)). Courts determine which party bears the burden of proof for a laches claim “by identifying ‘the most analogous statute of limitation as a guideline,’ and then determining whether that period has expired.”2 Id. at 444

2 The Court reads Defendants’ submission as a concession that they have the burden of proving their laches defense, as neither party addresses whether the statute of limitations has expired. This is important because when evaluating laches defenses in the context of the Lanham Act, courts must first assess whether the most analogous statute of limitation period has expired. Kars 4 Kids II, 98 (quoting Santana Prods., 401 F.3d at 135). If that period has expired, the burden shifts to the plaintiff, and the Lanham Act claims are barred unless the plaintiff establishes that: (1) its delay in suing was excusable; and (2) the delay did not

prejudice the defendant. Id. (citation omitted). Courts analogize Lanham Act claims to New Jersey’s fraud statute and, therefore, apply a six-year statute of limitations. See Kars 4 Kids Inc. v. Am. Can!, 8 F.4th 209, 221 (3d Cir. 2021) [hereinafter “Kars 4 Kids I”] (quoting Kaufhold v. Caiafa, 872 F. Supp. 2d 374, 379 (D.N.J. 2012)). The laches clock begins to run when a plaintiff “knows or should know about the existence of a provable claim.” DeWulf v. Blatt

Free access — add to your briefcase to read the full text and ask questions with AI

Novartis AG, et al. v. Novadoz Pharmaceuticals LLC, et al., (D.N.J. 2026).

Novartis AG, et al. v. Novadoz Pharmaceuticals LLC, et al. (Novartis AG, et al. v. Novadoz Pharmaceuticals LLC, et al.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Michael Churma v. United States Steel Corporation
514 F.2d 589 (Third Circuit, 1975)
Bayer AG v. Betachem, Inc.
173 F.3d 188 (First Circuit, 1999)
Fair Wind Sailing Inc v. H. Dempster
764 F.3d 303 (Third Circuit, 2014)
John Daubert v. NRA Group LLC
861 F.3d 382 (Third Circuit, 2017)
Securacomm Consulting, Inc. v. Securacom Inc.
224 F.3d 273 (Third Circuit, 2000)
Octane Fitness, LLC v. Icon Health
134 S. Ct. 1749 (Supreme Court, 2014)
Kaufhold v. Caiafa
872 F. Supp. 2d 374 (D. New Jersey, 2012)
Illinois Tool Works, Inc. v. MOC Products Co.
946 F. Supp. 2d 1042 (S.D. California, 2012)
Goodman v. Burlington Coat Factory Warehouse Corp.
292 F.R.D. 230 (D. New Jersey, 2013)
Wisniewski v. Johns-Manville Corp.
812 F.2d 81 (Third Circuit, 1987)
Parsons v. Jefferson-Pilot Corp.
141 F.R.D. 408 (M.D. North Carolina, 1992)
Kars 4 Kids Inc v. America Can Cars For Kids
98 F.4th 436 (Third Circuit, 2024)